3 / 31
Page 25
Notes:
conferenceseries
.com
Volume 7, Issue 6 (Suppl)
J Alzheimers Dis Parkinsonism, an open access journal
ISSN: 2161-0460
Dementia 2017
October 16-18, 2017
ALZHEIMER’S DISEASE & DEMENTIA
October 16-18, 2017 | Rome, Italy
9
th
International Conference on
Aromatherapy versus pharmaceutical interventions for Dementia related behaviors
Vanessa Veit
Massachusetts College of Pharmacology, USA
T
he elderly population is expected to double in the next thirty years increasing the number of individuals with the diagnosis
of dementia. By proxy, dementia related behaviors such as agitation, anxiety and restless will also increase. Currently,
pharmaceutical management of these behaviors include Ativan, Haldol and other psychotropic drugs which have side effects
that place individuals at risk for falls and at times even aggravate the behaviors. Although, not widely researched, aromatherapy
is a safe alternative to treating Dementia related behaviors. The purpose of this integrative literature review is to investigate
the correlation and efficacy of aromatherapy with dementia related behaviors and discuss the safety issues with psychotropic
medications. Fourteen articles supporting the notion that aromatherapy is a quality alternative to the use of psychotropic drugs.
Findings show aromatherapy has a calming effect on the body which can be measured physiologically as well as psychotropic
medications increase mortality risks.
Biography
Vanessa Veit has completed her MSN at the age of 41 years from Massachusetts College of Pharmacology and Health Sciences in May 2017. She has experience
in hospice and as a Director of Nursing in Long Term Care.
vlvmvc1@aol.comVanessa Veit, J Alzheimers Dis Parkinsonism 2017, 7:6(Suppl)
DOI: 10.4172/2161-0460-C1-033